Increasing evidence is connecting the host’s metabolic response in the pulmonary and extra-pulmonary organs in patients with severe COVID-19 with a deficiency of activity of AMP-activated protein kinase (AMPK), a major sensor of energy metabolism in all cells. The gene discussed is PRKAA1; the disease is COVID-19.